Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4781601046
Ticker JNJ
Company JOHNSON & JOHNSON
Currency $
Price
Aware Investor Index (AII) 4.7110
Recommendation BUY
P/E 27.62
ROE 17.70 %
Capitalization 347,758,827,000 $
Dividend Yield 2.39 %
P/S 4.96
AII Position 141
P/E Position 349
ROE Position 196
Capitalization Position 9
Dividend Yield Position 268
Sales 70,074,000,000 $
10-Year Average Earnings 12,592,700,000 $
Shares Outstanding 2,812,900,000
Equity 71,150,000,000 $
Dividend per Share 2.95 $
Industry Personal Care
Country United States
JOHNSON & JOHNSON Investor Relations Web Site http://www.investor.jnj.com/investor-relations.cfm







Sales:

YEAR MONTH AMOUNT
2015 12 70,074,000,000.00 $
2014 12 74,331,000,000.00 $
2013 12 71,312,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 15,409,000,000.00 $
2014 12 16,323,000,000.00 $
2013 12 13,831,000,000.00 $
2012 12 10,514,000,000.00 $
2011 12 9,672,000,000.00 $
2010 12 13,334,000,000.00 $
2009 12 12,266,000,000.00 $
2008 12 12,949,000,000.00 $
2007 12 10,576,000,000.00 $
2006 12 11,053,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 71,150,000,000.00 $
2014 12 69,752,000,000.00 $
2013 12 74,053,000,000.00 $
2012 12 64,826,000,000.00 $
2011 12 57,080,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 2,812,900,000
2014 12 2,863,900,000
2013 12 2,877,000,000
2012 12 2,812,600,000
2011 12 2,775,300,000

 












Bloomberg News for JOHNSON & JOHNSON:

Apr 17, 2017
U.S. Stocks Climb on Low Volume as Real Estate, Tech Shares Gain
Harley-Davidson (HOG), UnitedHealth Group (UNH), Progressive (PGR), Omnicom Group (OMC), Johnson & Johnson (JNJ), Comerica (CMA), Bank of America (BAC), Goldman Sachs (GS), W.W. Grainger (GWW), Prologis (PLD)For...
Aug 4, 2010
Arbitrage Profit in U.S. Takeovers Pending on Aug. 4
09/30/10 BSMD US MMSI US 4.38 4.35 0.03 0.69 30,433 Cash 09/30/10 MEND US JNJ US 23.40 23.24 0.16 0.69 168,901 Cash 12/31/10 ODSY US GTIV US 27.00 ...
Jan 3, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
Volume ============================================================================= JNJ JOHNSON&JOH JNJ US 02/19/11 P65 159.3 16.3 2.72 -23.4 2170 IWM ISHARES-RUS IWM US 01/22/11...
Apr 17, 2007
Wells Fargo, Charles Schwab & More Post Higher Earnings
$0.47 first quarter earnings per share (EPS) on a 17% revenue rise. Johnson & Johnson (JNJ) Posts $1.16 vs. $0.99 first quarter EPS excluding items on a 16% sales rise. Wells Fargo...
Sep 13, 2007
A New Risk to the Credit Markets
largest issuers include GE, Morgan Stanley (MS), Ford Motor (F), AT&T (T), Johnson & Johnson (JNJ), and IBM (IBM). While few people outside of the world of finance have heard of the asset-backed...
Sep 4, 2007
Google's New Role: Venture Capitalist
helped boost the first-half numbers, according to the NVCA‚ÄĒNovartis (NVS) and Johnson & Johnson (JNJ) were among the biggest U.S. investors. In the tech sector, Intel Capital invested $236 million...
Aug 14, 2007
The Name of the Game Is Work
Royal Philips Electronics (PHG), and Johnson & Johnson Pharmaceutical Research & Development (JNJ) are bringing games with 3D computer graphics into the workplace to appeal to the generation raised...
Jul 31, 2007
S&P Picks and Pans: J&J, CBS, Morgan Stanley, Under Armour
Johnson & Johnson (JNJ; $61.18) Maintains 4 STARS (buy) Analyst: Robert Gold The company announces a much-anticipated, in our view, restructuring intended to align its cost structure...
May 26, 2003
J&J: Subpoena and Subpoena
Johnson & Johnson (JNJ) is the latest health-care company to come under scrutiny for its marketing. On May 14, J&J disclosed in an SEC filing that it has received subpoenas from the New York State...
Apr 9, 2003
Stocks End with Losses
arthritis drug Humira which will compete against Amgen's (AMGN ) Enbrel and Johnson & Johnson's (JNJ ) Remicade. For the first quarter, Genentech's earnings per share increased 59% to 35 cents...


Google News for JOHNSON & JOHNSON:

Nasdaq - 13 hours ago
August 18th Options Now Available For Johnson & Johnson (JNJ)
Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the August 18th expiration. One of the key data points ...
NY Stock News - 18 hours ago
The Technical Chart For Johnson & Johnson (JNJ) Is Speaking ...
Johnson & Johnson (JNJ) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors ...
Equities.com
Johnson & Johnson leads the Dow higher after JPMorgan upgrades ...
JPMorgan upgraded Johnson & Johnson to overweight from neutral and hiked ... J&J is coming off a disappointing first quarter, and the second ...
Sports Perspectives
Why Is Johnson & Johnson (JNJ) Up 4.4% Since the Last Earnings ...
A month has gone by since the last earnings report for Johnson & JohnsonJNJ . Shares have added about 4.4% in the past month, ...
TopChronicle
Johnson & Johnson (JNJ) Near Deal to Sell Compeed for $1B ...
Johnson & Johnson (NYSE: JNJ) is close to selling its Compeed blister cushion business for about $1 billion, according to a person claiming to ...
CNBC - 15 May 2017
Johnson & Johnson plans to file for approval 10 potential ...
Johnson & Johnson JNJ, +0.39% said Wednesday that it, along with its Janssen Pharmaceutical Companies, plans to file for regulatory ...
Benzinga
Johnson & Johnson's stock jumps after analyst turns bullish for first ...
Shares of Johnson & Johnson JNJ, +0.02% jumped 1.9% in midday trade Monday, after J.P. Morgan turned bullish on the health care products ...
StreetInsider.com
Johnson & Johnson: Buy And Hold Forever
Johnson & Johnson (NYSE:JNJ) is a multinational pharmaceutical, consumer products and medical equipment company which has stood the ...
Investorplace.com
The world's largest drugmaker thinks it has 11 billion-dollar drugs in ...
Johnson & Johnson just listed out the drugs it plans to file for approval over the next few years that could be "blockbusters." These are drugs ...
Nasdaq - 3 days ago
J&J ordered to pay $110 million in US talc-powder trial
Johnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian ...


Back